South Korea vs Qatar: Hepatitis B surface antigen (HBsAg) prevalence
South Korea
0.0%
in 2024
Qatar
0.0%
in 2024
South Korea rank
132nd
Qatar rank
132nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- South Korea
- Qatar
How they compare
South Korea currently reports 0.0% against 0.0% in Qatar, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Qatar ahead.
South Korea ranks 132nd and Qatar ranks 132nd of 194 countries.
South Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Korea | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | — |
| 2020s | 0.0% | 0.0% | 0.0% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, South Korea or Qatar?
- South Korea, at 0.0% against 0.0% in Qatar as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between South Korea and Qatar?
- 0.0%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Qatar?
- 10 years are reported by both, from 2015 to 2024.
- How do South Korea and Qatar rank globally for hepatitis b surface antigen (hbsag) prevalence?
- South Korea ranks 132nd and Qatar ranks 132nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.